Ferreira Juan Camilo Arjona Organon & Co. (OGN) insider trading activity

Ferreira Juan Camilo Arjona is Head of R&D & CMO of Organon & Co.. Currently has a direct ownership of 28,916 shares of OGN, which is worth approximately $217,737. The most recent transaction as insider was on Nov 07, 2025, when has been sold 2,307 shares (Common Stock) at a price of $6.71 per share, resulting in proceeds of $15,479. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.9K

16.71% 3M change

147.42% 12M change

Total Value Held $217,737

Ferreira Juan Camilo Arjona Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 07 2025	SELL Payment of exercise price or tax liability	$15,479 $6.71 p/Share	2,307 Reduced 7.39%	28,916 Common Stock
Nov 07 2025	BUY Exercise of conversion of derivative security	-	6,446 Added 17.11%	31,223 Common Stock
Aug 11 2025	SELL Payment of exercise price or tax liability	$38,004 $9.22 p/Share	4,122 Reduced 14.26%	24,777 Common Stock
Aug 11 2025	BUY Exercise of conversion of derivative security	-	11,519 Added 28.5%	28,899 Common Stock
Mar 31 2025	SELL Payment of exercise price or tax liability	$46,025 $14.51 p/Share	3,172 Reduced 15.43%	17,380 Common Stock
Mar 31 2025	BUY Exercise of conversion of derivative security	-	8,865 Added 30.14%	20,552 Common Stock
Nov 07 2024	SELL Payment of exercise price or tax liability	$36,340 $15.8 p/Share	2,300 Reduced 16.44%	11,687 Common Stock

Nov 07 2024	BUY Exercise of conversion of derivative security	-	6,446 Added 31.55%	13,987 Common Stock
Aug 11 2024	SELL Payment of exercise price or tax liability	$80,418 $20.15 p/Share	3,991 Reduced 34.61%	7,541 Common Stock
Aug 11 2024	BUY Exercise of conversion of derivative security	-	11,519 Added 49.97%	11,532 Common Stock

Also insider at

MYOV

Myovant Sciences Ltd. Healthcare

Chief Medical Officer

FJC